Idexx Laboratories ( (IDXX) ) has shared an update. Jonathan W. Ayers, former Chairman and CEO of IDEXX Laboratories, has resigned from the ...

Shares of IDEXX Laboratories Inc. IDXX inched 0.87% higher to $429.82 Wednesday, on what proved to be an all-around positive ...

Shares of IDEXX Laboratories Inc. IDXX inched 0.06% higher to $433.28 Friday, on what proved to be an all-around great ...

Idexx Laboratories reported a strong earnings beat for Q3 2024, but reduced its revenue guidance. Idexx Laboratories, a global leader in veterinary diagnostics, focuses on providing a wide range ...

Idexx Laboratories ( (IDXX) ) has released its Q3 earnings. Here is a breakdown of the information Idexx Laboratories presented to its ...

Idexx delivered another quarter of unusually muted companion animal growth (up 7% year over year) and lowered management outlook again, sending shares swooning 9% in premarket trading. We have ...

Idexx Laboratories Adjusts Guidance As Q3 Revenue Growth Slows, Analyst Notes Fewer Veterinary Visits, Looks Towards Long-Term Growth Idexx Laboratories posted a Q3 EPS of $2.79, beating estimates ...

Barclays lowered the firm’s price target on Idexx Laboratories (IDXX) to $481 from $570 and keeps an Overweight rating on the shares. The firm sees the softer visit trends continuing based on ...

Ratings for IDEXX Laboratories (NASDAQ:IDXX) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table provides a quick ...

Wall Street expects a year-over-year increase in earnings on higher revenues when Idexx Laboratories (IDXX) reports results for the quarter ended September 2024. While this widely-known consensus ...

The Animal diagnostic and health care company posted revenue of $975.5 million in the period, which did not meet Street forecasts. Five analysts surveyed by Zacks expected $979.6 million. Idexx ...